1. Market Research
  2. > Pharmaceutical Market Trends
  3. > PharmaLeaders: Global Pharmaceutical Market Benchmark Report - Retrospective and Forward-Looking Analysis of the Leading Pharmaceutical Companies

PharmaLeaders: Global Pharmaceutical Market Benchmark Report - Retrospective and Forward-Looking Analysis of the Leading Pharmaceutical Companies

  • October 2014
  • -
  • GlobalData
  • -
  • 376 pages

Summary

Table of Contents

PharmaLeaders: Global Pharmaceutical Market Benchmark Report - Retrospective and Forward-Looking Analysis of the Leading Pharmaceutical Companies

Summary

The Global Pharmaceutical Market Benchmark Report applies GlobalData’s proprietary ranking methodology to compare the competitive positions of 30 leading drug companies on 25 financial metrics. These companies are analyzed based on financial performance, cost-containment, capital structure, and firm utilization to illustrate the different strategies these companies are using to increase value for their shareholders and create a competitive advantage. Throughout the report, GlobalData’s Industry Dynamics Team provides expert insight, expanding on each of the metrics discussed.

In addition to the financial metrics, this report discusses trends impacting the pharmaceutical marketplace including FDA approvals, patent/generic erosion, regulatory changes, and the impact of the ACA on Rx, along with partnering and acquisition activity, and operations strategy. The report also provides a drill-down analysis identifying the revenue and growth leaders across 4 geographic regions (US, EU, Japan/Asia, and Emerging markets), and 11 therapeutic franchises. Lastly, this report provides GlobalData’s outlook on the Global Pharmaceutical market, and each company’s future competitive position including six-year forecasts for all 30 companies covered in the report.

Highlights

About the Report

GlobalData identified these 30 leading drug companies to apply its benchmarking methodology providing a foundation for strategic discussion and analysis. GlobalData’s coverage examines these companies from a unique company-centric lens - combining financial performance and resources allocation with partnering activity and regional developments to assess a company’s overall strategy. This type of coverage is unlike any other analysis available, and delivers a consistent view into the evolution of these companies’ corporate growth.

Key Questions Answered

- What specific strategies are these drug companies employing to gain market share?
- What drivers accounted for the revenue growth for the company over the past year?
- Which trends will affect the global pharmaceutical market over the next few years?
- Who are the revenue and growth leaders in each therapeutic and geographical area?
- What specific business development activities are taking place, in terms of partnerships or M&A?
- What are the top-selling drugs in each therapeutic franchise and what are their sales forecasts through 2019?

Scope

- This report provides analysis of the key drivers and trends shaping the global pharmaceutical market; including drivers of financial growth and R&D spending, FDA approvals, generic erosion, corporate strategy, orphan drugs and asset value creation
- This report offers a deep dive into the synergies behind partnering and acquisition activity
- Covers 11 therapeutic franchises; market sizing, growth rates, company share, sales drivers of top drugs, pipeline movements, sales forecasts and product NPVs
- Assessments of company financials by revenue, margin, expense and capital structure
- Revenue and growth leaders across 4 geographies; US, EU, Japan/Asia, Emerging markets
- Firm utilization, efficiency metrics, capital ratios, headcount analytics

Reasons to buy

- Analyze and track the strategies that these drug companies are using to gain share in the increasingly competitive market
- Understand the underlying financial metrics that differentiate certain companies from the pack in terms of growth and profitability, spending and asset structure
- Identifies the important disease areas, types of products, and geographical areas where companies are expanding to ensure their future success
- Independent source to benchmark your company’s performance against a similar peer group to assess areas of strength/weakness

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.